Met Life Investment Management, LLC Guardant Health, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 72,149 shares of GH stock, worth $3.08 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
72,149
Previous 68,147
5.87%
Holding current value
$3.08 Million
Previous $1.56 Million
41.1%
% of portfolio
0.01%
Previous 0.01%
Shares
47 transactions
Others Institutions Holding GH
# of Institutions
347Shares Held
120MCall Options Held
793KPut Options Held
1.85M-
Vanguard Group Inc Valley Forge, PA12.1MShares$514 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$479 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.42MShares$274 Million8.64% of portfolio
-
Baillie Gifford & CO5.45MShares$232 Million0.13% of portfolio
-
Cadian Capital Management, LP New York, NY5.22MShares$223 Million9.25% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.36B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...